Skip to main content
logo
Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
3.100
+0.025 (0.81%)
At close: Aug 25, 2026, 4:00 PM EDT
3.030
-0.070 (-2.26%)
After-hours: Aug 25, 2026, 7:59 PM EDT

Acumen Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
224128103222221274
Market Cap Growth
141.90%23.68%-53.53%0.62%-19.22%-
Enterprise Value
14623-126-602144
Last Close Price
3.102.111.723.845.406.76

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.911.820.570.831.171.22
P/TBV Ratio
3.921.820.570.831.171.22

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.550.450.160.120.00-
Net Debt / Equity Ratio
-1.37-1.22-1.11-1.03-1.02-1.00
Net Debt / EBITDA Ratio
0.750.691.774.504.2811.54
Net Debt / FCF Ratio
0.860.742.346.385.4812.55
Inventory Turnover
---284.97229.51141.44
Quick Ratio
2.383.936.2418.8122.7537.76
Current Ratio
2.474.076.4619.0123.0838.60
Return on Equity (ROE)
-120.50%-96.20%-45.60%-22.98%-20.71%-76.44%
Return on Assets (ROA)
-45.77%-42.78%-25.96%-15.08%-13.25%-8.91%
Return on Capital Employed (ROCE)
-152.40%-133.40%-53.90%-20.60%-24.00%-8.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-46.86%-94.93%-99.02%-23.55%-19.39%-36.77%
FCF Yield
-40.94%-90.47%-83.45%-19.38%-15.98%-6.58%
Buyback Yield / Dilution
-6.39%-0.91%-23.46%-19.72%-102.43%-4685.59%
SEC Filings: 10-K · 10-Q